Related Experiment Video

Updated: Oct 10, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

Regression of HIV-associated progressive encephalopathy of childhood during HAART

V Rosenfeldt1, N H Valerius, A Paerregaard

  • 1Department of Paediatrics, Copenhagen University Hospital Hvidovre, Denmark.

Scandinavian Journal of Infectious Diseases
|October 31, 2000
PubMed

Insights

This study explores the impact of a 3-drug antiretroviral therapy, including nelfinavir, on a child with HIV-associated encephalopathy. The findings suggest potential benefits of this combination therapy for managing neurological decline in pediatric HIV.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Neuroimmunology

Background:

  • HIV-associated encephalopathy (HAE) in children presents with cognitive decline, impaired brain growth, and motor dysfunction.
  • Diagnosis relies on neurological exams, neuropsychological testing, and neuroimaging (CT/MRI).
  • While early antiretroviral therapy is crucial, data on protease inhibitors in pediatric HAE are limited.

Observation:

  • A 7-year-old girl with vertically acquired HIV infection developed late-onset progressive encephalopathy.
  • She was treated with a 3-drug antiretroviral combination therapy regimen.
  • This regimen included the protease inhibitor nelfinavir.

Findings:

  • The study describes the observed effects of this specific antiretroviral combination therapy.
  • The therapy aimed to manage the neurological and cognitive decline associated with HAE.
  • The case report details the clinical response to nelfinavir-containing treatment.

Implications:

  • This case highlights the potential role of protease inhibitors like nelfinavir in managing pediatric HAE.
  • Further research is needed to establish the efficacy of such regimens in larger pediatric cohorts.
  • Early and effective antiretroviral strategies are critical for improving neurological outcomes in children with HIV.

More Related Videos

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

A Rat Model of EcoHIV Brain Infection08:48

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...